MD
Veradigm Inc.
MDRX · OTC
$4.85 +3.19% (+$0.15)
1M -1.02%
Market Cap $862.7M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
5/9Valuation
88 /100
Cheap EV/EBITDA 10.88x
P/FCF 10.36x
P/S 1.47x
Growth
0 /100
Declining Rev. growth 28.85%
Book val. growth 7.49%
EPS growth N/A
Profitability
45 /100
Moderate Gross margin 52.45%
FCF margin 14.17%
Net margin 14.70%
Quality
7 /100
Poor ROIC 0.66%
Asset turnover 0.39x
ROA 5.75%
Debt
80 /100
Low Debt/Equity 0.22x
Net debt/EBITDA -3.89x
Current ratio 2.95x
Stability
29 /100
Unstable Beta 0.56x
Profitable years 0
Rev. volatility 34.14%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o MDRX
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Donald D. Trigg
Employees
2,300
Headquarters
Chicago
Nadchodzące wydarzenia
06 LIS
Earnings
Upcoming earnings report